---
title: How I use Maintenance Therapy in Acute Myeloid Leukemia
date: '2024-10-07'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39374534/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20241007200551&v=2.18.0.post9+e462414
source: Blood
description: Outcomes for acute myeloid leukemia have improved significantly in the
  last decade with the approval of novel therapeutics targeting diverse vulnerabilities
  of leukemic cells, expanded access to stem cell transplantation, and improved safety
  of transplantation. While attainment of initial remission is now an expected outcome
  in most AML patients receiving intensive or non-intensive induction regimens, maintaining
  long-term remission and decreasing the risk of relapse remain critical ...
disable_comments: true
---
Outcomes for acute myeloid leukemia have improved significantly in the last decade with the approval of novel therapeutics targeting diverse vulnerabilities of leukemic cells, expanded access to stem cell transplantation, and improved safety of transplantation. While attainment of initial remission is now an expected outcome in most AML patients receiving intensive or non-intensive induction regimens, maintaining long-term remission and decreasing the risk of relapse remain critical ...